Literature DB >> 12110328

Novel substrates for nitric oxide synthases.

Ming Xian1, Noriko Fujiwara, Zhong Wen, Tingwei Cai, Satoshi Kazuma, Adam J Janczuk, Xiaoping Tang, Vladislav V Telyatnikov, Yingxin Zhang, Xinchao Chen, Yasuhide Miyamoto, Naoyuki Taniguchi, Peng George Wang.   

Abstract

Enzymatic generation of nitric oxide (NO) by nitric oxide synthase (NOS) consists of two oxidation steps. The first step converts L-arginine to N(G)-hydroxy-L-arginine (NOHA), a key intermediate, and the second step converts NOHA to NO and L-citrulline. To fully probe the substrate specificity of the second enzymatic step, an extensive structural screening was carried out using a series of N-alkyl (and N-aryl) substituted-N'-hydroxyguanidines (1-14). Among the eleven N-alkyl-N'-hydroxyguanidines evaluated, N-n-propyl (2), N-iso-propyl (3), N-n-butyl (4), N-s-butyl (5), N-iso-butyl (6), N-pentyl (8) and N-iso-pentyl (9) derivatives were efficiently oxidized by the three isoenzymes of NOS (nNOS, iNOS and eNOS) to generate NO. N-Butyl-N'-hydroxyguanidine (4) was the best substrate for iNOS (K(m)=33 microM) and N-iso-propyl-N'-hydroxyguanidine (3) was the best substrate for nNOS (K(m)=56 microM). When the alkyl substituents were too small (such as ethyl 1) or too large (such as hexyl 10 and cyclohexyl 11), the activity decreased significantly. This suggests that the van der Waals interaction between the alkyl group and the hydrophobic cavity in the NOS active site contributes significantly to the relative reactivity of compounds 3-11. Moreover, five N-aryl-N'-hydroxyguanidines were found to be good substrates for iNOS, but not substrates for eNOS and nNOS. N-phenyl-N'-hydroxyguanidine was the best substrate among them (K(m)=243 microM). This work demonstrates that N-alkyl substituted hydroxyguanidine compounds are novel NOS substrates which 'short-circuit' the first oxidation step of NOS, and N-aryl substituted hydroxyguanidine compounds are isoform selective NOS substrate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110328     DOI: 10.1016/s0968-0896(02)00155-4

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Synthesis of phidianidines A and B.

Authors:  Hong-Yu Lin; Barry B Snider
Journal:  J Org Chem       Date:  2012-05-01       Impact factor: 4.354

2.  A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.

Authors:  Qingzhi Zhang; Agnieszka Kulczynska; David J Webb; Ian L Megson; Nigel P Botting
Journal:  Chem Commun (Camb)       Date:  2013-02-18       Impact factor: 6.222

3.  Arginase blockade protects against hepatic damage in warm ischemia-reperfusion.

Authors:  Geetha Jeyabalan; John R Klune; Atsunori Nakao; Nicole Martik; Guoyao Wu; Allan Tsung; David A Geller
Journal:  Nitric Oxide       Date:  2008-04-14       Impact factor: 4.427

4.  Single crystal structural and absorption spectral characterizations of nitric oxide synthase complexed with N(omega)-hydroxy-L-arginine and diatomic ligands.

Authors:  Tzanko Doukov; Huiying Li; Michael Soltis; Thomas L Poulos
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

Review 5.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

Review 6.  Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.

Authors:  Gonçalo S Clemente; Aren van Waarde; Inês F Antunes; Alexander Dömling; Philip H Elsinga
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

7.  Crambescin C1 Acts as A Possible Substrate of iNOS and eNOS Increasing Nitric Oxide Production and Inducing In Vivo Hypotensive Effect.

Authors:  Juan A Rubiolo; Emilio Lence; Concepción González-Bello; María Roel; José Gil-Longo; Manuel Campos-Toimil; Eva Ternon; Olivier P Thomas; Antonio González-Cantalapiedra; Henar López-Alonso; Mercedes R Vieytes; Luis M Botana
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

Review 8.  Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease.

Authors:  Sergei A Kharitonov; Peter J Barnes
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

9.  Netrin-1 is a novel regulator of vascular endothelial function in diabetes.

Authors:  Haroldo A Toque; Aracely Fernandez-Flores; Riyaz Mohamed; Ruth B Caldwell; Ganesan Ramesh; R William Caldwell
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

10.  Synthesis and hyperpolarisation of eNOS substrates for quantification of NO production by 1H NMR spectroscopy.

Authors:  Fernando Fernandez Diaz-Rullo; Francesco Zamberlan; Ryan E Mewis; Marianna Fekete; Lionel Broche; Lesley A Cheyne; Sergio Dall'Angelo; Simon B Duckett; Dana Dawson; Matteo Zanda
Journal:  Bioorg Med Chem       Date:  2017-03-21       Impact factor: 3.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.